Annals of Surgical Oncology

, Volume 10, Issue 8, pp 827–828 | Cite as

Management of Peritoneal Carcinomatosis: Is an Answer at Hand?

  • Paul F. MansfieldEmail author


  1. 1.
    Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003;10:863–9.CrossRefGoogle Scholar
  2. 2.
    Zoetmulder FA, Verwaal VJ, Ruth S. Hyperthermic intra peritoneal chemotherapy (HIPEC) with mitomycin C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin. Paper presented at: Proceedings of the 38th Annual Meeting of the American Society of Clinical Oncology; May 19, 2002; Orlando, FL.Google Scholar
  3. 3.
    Alexander HR. A prospective random assignment trial for patients with peritoneal carcinomatosis from low-grade gastrointestinal adenocarcinoma to treatment with operative debulking and systematic chemotherapy with or without intra- and peri-operative intraperitoneal chemotherapy. Paper presented at: American College of Surgeons Oncology Group; June 6, 2003; Montreal, Canada.Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2003

Authors and Affiliations

  1. 1.Department of Surgical OncologyUniversity of Texas M.D. Anderson Cancer CenterHouston
  2. 2.Department of Surgical OncologyUniversity of Texas M.D. Anderson Cancer CenterHouston

Personalised recommendations